PAVmed
PAVM
22 hedge funds and large institutions have $932K invested in PAVmed in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
10% more funds holding
Funds holding: 20 → 22 (+2)
0.04% more ownership
Funds ownership: 0.35% → 0.39% (+0.04%)
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
54% less capital invested
Capital invested by funds: $2.03M → $932K (-$1.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
+$125K |
| 2 |
AA
Axiom Advisory
San Diego,
California
|
+$64.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$41.9K |
| 4 |
VF
Virtu Financial
New York
|
+$25.1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VFA
Valeo Financial Advisors
Carmel,
Indiana
|
-$39.1K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.58K |
| 3 |
SSG
Summit Securities Group
New York
|
-$8K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$5.38K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$648 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VFA
26
Valeo Financial Advisors
Carmel,
Indiana
| – | -$39.1K | -704 | Closed |
|
|
SSG
27
Summit Securities Group
New York
| – | -$8K | -120 | Closed |
|
|
28
Simplex Trading
Chicago,
Illinois
| – | -$648 | -13 | Closed |
|
|
NFSG
29
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$287 | -4 | Closed |
|
PAVM Hedge Fund Activity: Q2 2024 in Review
22 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q2 2024, worth a combined $932K — down 54% from $2.03M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new PAVM positions and 4 closed out — a net gain of 2 holders — while 3 added to existing stakes and 5 trimmed.
The largest buyer was First Manhattan, adding an estimated $125K. The largest seller was Valeo Financial Advisors, exiting entirely with an estimated $39.1K sold.
- 22 institutional investors held PAVmed (PAVM) as of Q2 2024, up from 20 in Q1 2024.
- Funds reported $932K of PAVmed stock for Q2 2024, down 54% quarter-over-quarter.
- 6 funds opened new PAVmed positions in Q2 2024 and 4 closed out, a net change of +2 holders.
- The largest PAVmed buyer in Q2 2024 was First Manhattan, an estimated $125K added.
- The largest PAVmed seller in Q2 2024 was Valeo Financial Advisors, an estimated $39.1K sold.
Based on aggregated 13F filings for Q2 2024.